Abstract:Abstract Background Diabetic nephropathy is closely related to immune-regulation, in which macrophages play a crucial role. In diabetic nephropathy, the classically activated macrophages (M1) increased while the alternatively activated macrophages (M2) decreased in kidney. Mesenchymal stem cells (MSCs) administration can alleviate diabetic nephropathy, however, the mechanisms still remain unclear. MSCs have been shown to stimulate macrophages from a M1 phenotype to a M2 phenotype. Thus, we aimed to investigate whether the polarization of M1/M2 induced by MSCs was involved in diabetic nephropathy (DN). Methods In our study, we injected human umbilical cord mesenchymal stem cells (UC-MSCs) into type 2 diabetic nephropathy rats induced by high fat diet combined with a low dose of streptozotocin. To clarify the effect of MSCs on macrophages polarization, peritoneal macrophages were extracted and directed into M1 macrophages by lipopolysaccharides (LPS) in vitro. Then we co-cultured UC-MSCs with M1 macrophages, and evaluated the effect on differentiation. We also co-cultured rat glomerular mesangial cells (HBZY-1) in high-glucose DMEM with LPS-stimulated macrophages (M1 macrophages) or UC-MSCs-induced M2 macrophages in a trans-well system to clarify the complex mechanisms by which UC-MSCs-induced M2 macrophages improve the progression of DN. Results The UC-MSCs infusion reduced the infiltration of M1 macrophages, and increased the infiltration of M2 macrophages in the glomerulus, thereby attenuating histopathological renal damage and improving renal inflammation and fibrosis in diabetic nephropathy rats. After coculturing UC-MSCs with M1 macrophages, we found that the M1 macrophage maker inducible nitric oxide synthase (NOS2) and the mRNA and protein levels of the related pro-inflammatory cytokines TNF-α, TGF-β and IL-1β decreased. However, the expression of the M2 macrophage markers CD163 and CD206, as well as the anti-inflammatory cytokine IL-10 increased observably. Furthermore, UC-MSCs increased the expression of IL-4Rα on macrophages by secreting IL-6; blocking IL-6 secretion inhibited the UC-MSCs effect on M2 macrophage polarization. Then we explored the mechanism by which M2 macrophages ameliorate diabetic nephropathy in vitro and found that UC-MSCs-induced M2 macrophages attenuated the secretion of the chemokine monocyte chemoattractant protein-1(MCP-1) in hyperglycemia-induced mesangial cells, which led to reduce macrophage recruitment and infiltration. Moreover, UC-MSCs-induced M2 macrophages inhibited TGF-β in glomerular mesangial cells, thereby reducing the synthesis of collagen I and collagen IV. Conclusions Our study proposes and discusses a mechanism by which MSCs promote the polarization of macrophages from M1 into M2 in the kidney, thereby ameliorating diabetic nephropathy.

NSUN2 knockdown inhibits macrophage infiltration in diabetic nephropathy via reducing N5-methylcytosine methylation of SOCS1

NSUN2 affects diabetic retinopathy progression by regulating MUC1 expression through RNA m5C methylation

METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy

Urinary stem cell-derived exocrine circRNA ATG7 regulates the SOCS1/STAT3 signaling pathway through miR-4500, inhibits M1 macrophage polarization, and alleviates the progression of diabetes nephropathy

MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization

LncRNA SNHG14 silencing attenuates the progression of diabetic nephropathy via the miR‐30e‐5p/SOX4 axis

Silencing long noncoding RNA-CES1P1 suppresses glomerular endothelial cell inflammation in diabetic nephropathy

Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-ĸB-Dependent Inflammation

MiR-214 Promotes Renal Fibrosis in Diabetic Nephropathy Via Targeting SOCS1

Mesenchymal stem cells polarize macrophages to an anti-inflammatory phenotype to ameliorate diabetic nephropathy

NSun2 Deficiency Protects Endothelium from Inflammation Via Mrna Methylation of ICAM-1

Repurposing Niclosamide to Modulate Renal RNA-Binding Protein HuR for the Treatment of Diabetic Nephropathy in db/db Mice

Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy Via Suppression of MAPK/NF-κB- Dependent Inflammation.

miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1

Unraveling the nexus of NAD+ metabolism and diabetic kidney disease: insights from murine models and human data

MiRNA-133a-3p Attenuates Renal Tubular Epithelial Cell Injury via Targeting MALM1 and Suppressing the Notch Signaling Pathway in Diabetic Nephropathy

LINC01232 targeting miR-1250-3p/MSH2 axis attenuates mesangial cell proliferation and fibrosis in diabetic nephropathy

RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer

Downregulation of Salusin-β protects renal tubular epithelial cells against high glucose-induced inflammation, oxidative stress, apoptosis and lipid accumulation via suppressing miR-155-5p

NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy

NSUN2 Promotes Head and Neck Squamous Cell Carcinoma Progression by Targeting EMT-Related Gene LAMC2 in an m5C-YBX1-Dependent Manner